Resibufogenin ameliorates cerebral ischemia-reperfusion injury by modulating microglial redox homeostasis via Keap1-Nrf2-TFR1/ARE axis

Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American heart association. Circulation. 2024;149:e347–913.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen TN, Abdalkader M, Fischer U, Qiu ZM, Nagel S, Chen HS, et al. Endovascular management of acute stroke. Lancet. 2024;404:1265–78.

Article  PubMed  Google Scholar 

Dhillon PS, White P, Goyal M, van Zwam WH, Lenthall R. Perfusion imaging in acute ischaemic stroke-the beginning of the end?. Clin Med. 2023;23:185–6.

Article  Google Scholar 

Krause GS, White BC, Aust SD, Nayini NR, Kumar K. Brain cell death following ischemia and reperfusion: a proposed biochemical sequence. Crit Care Med. 1988;16:714–26.

Article  PubMed  CAS  Google Scholar 

Watanabe T, Tahara M, Todo S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther. 2008;26:101–14.

Article  PubMed  CAS  Google Scholar 

Var SR, Shetty AV, Grande AW, Low WC, Cheeran MC. Microglia and macrophages in neuroprotection, neurogenesis, and emerging therapies for stroke. Cells. 2021;10:3555.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin SX, Shi CL, Zhao L, Xian L, Yang WW, Wang ZY, et al. The ubiquitination and degradation of SH2B3 mediated by MEF2A/WWP2 axis restores microglial homeostasis to alleviate cerebral microvascular endothelial cell injury in ischemic stroke. Neurochem Res. 2025;50:170.

Article  PubMed  CAS  Google Scholar 

Wu QY, Zou CY. Microglial dysfunction in neurodegenerative diseases via RIPK1 and ROS. Antioxidants. 2022;11:2201.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pan JR, Peng JL, Li XP, Wang HX, Rong XM, Peng Y. Transmission of NLRP3-IL-1β signals in cerebral ischemia and reperfusion injury: from microglia to adjacent neuron and endothelial cells via IL-1β/IL-1R1/TRAF6. Mol Neurobiol. 2023;60:2749–66.

PubMed  CAS  Google Scholar 

Guo KW, Shang YX, Wang Z, Yu L, Chen JL, Zhu BF, et al. BRG1 alleviates microglial activation by promoting the Keap1-Nrf2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia-reperfusion. Int Immunopharmacol. 2023;119:110201.

Article  PubMed  CAS  Google Scholar 

George M, Tharakan M, Culberson J, Reddy AP, Reddy PH. Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases. Ageing Res Rev. 2022;82:101756.

Article  PubMed  CAS  Google Scholar 

Dinkova-Kostova AT, Kostov RV, Canning P. Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. Arch Biochem Biophys. 2017;617:84–93.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yamamoto M, Kensler TW, Motohashi H. The Keap1-Nrf2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98:1169–203.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sun YY, Zhu HJ, Zhao RY, Zhou SY, Wang MQ, Yang Y, et al. Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice. Redox Biol. 2023;66:102852.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xu H, Shen JG, Xiao JB, Chen F, Wang MF. Neuroprotective effect of cajaninstilbene acid against cerebral ischemia and reperfusion damages by activating AMPK/Nrf2 pathway. J Adv Res. 2020;34:199–210.

Article  PubMed  PubMed Central  Google Scholar 

Porras CA, Rouault TA. Iron homeostasis in the CNS: an overview of the pathological consequences of iron metabolism disruption. Int J Mol Sci. 2022;23:4490.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Qian ZM, Ke Y. Brain iron transport. Biol Rev Camb Philos Soc. 2019;94:1672–84.

Article  PubMed  Google Scholar 

Vogt AS, Arsiwala T, Mohsen M, Vogel M, Manolova V, Bachmann MF. On iron metabolism and its regulation. Int J Mol Sci. 2021;22:4591.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tian HY, Huang BY, Nie HF, Chen XY, Zhou Y, Yang T, et al. The interplay between mitochondrial dysfunction and ferroptosis during ischemia-associated central nervous system diseases. Brain Sci. 2023;13:1367.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Han P, Wang X, Zhou TQ, Cheng JM, Wang CN, Sun F, et al. Inhibition of ferroptosis attenuates oligospermia in male Nrf2 knockout mice. Free Radic Biol Med. 2022;193:421–9.

Article  PubMed  CAS  Google Scholar 

Marro S, Chiabrando D, Messana E, Stolte J, Turco E, Tolosano E, et al. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position −7007 of the FPN1 promoter. Haematologica. 2010;95:1261–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Luo X, Wang YH, Zhu XX, Chen YW, Xu BY, Bai XX, et al. MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting Keap1/Nrf2 interaction. Redox Biol. 2024;69:102987.

Article  PubMed  CAS  Google Scholar 

Wang YL, Yan S, Liu XM, Deng F, Wang PC, Yang LY, et al. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway. Cell Death Differ. 2022;29:1982–95.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ryan SK, Zelic M, Han YN, Teeple E, Chen LM, Sadeghi M, et al. Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat Neurosci. 2023;26:12–26.

Article  PubMed  CAS  Google Scholar 

Duan WL, Ma YP, Wang XJ, Ma CS, Han B, Sheng ZM, et al. N6022 attenuates cerebral ischemia/reperfusion injury-induced microglia ferroptosis by promoting Nrf2 nuclear translocation and inhibiting the GSNOR/GSTP1 axis. Eur J Pharmacol. 2024;972:176553.

Article  PubMed  CAS  Google Scholar 

Uddin MN, Agunanne EE, Horvat D, Puschett JB. Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia. Hypertens Pregnancy. 2012;31:70–8.

Article  PubMed  CAS  Google Scholar 

Gao Y, Xu ZL, Li XM, Liu ZZ, Li WJ, Kang Y, et al. Resibufogenin, one of bufadienolides in toad venom, suppresses LPS-induced inflammation via inhibiting NF-κB and AP-1 pathways. Int Immunopharmacol. 2022;113:109312.

Article  PubMed  CAS  Google Scholar 

Han QR, Ma Y, Wang H, Dai Y, Chen CH, Liu YW, et al. Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis. J Transl Med. 2018;16:201.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen XY, Chen YJ, Zhai CG, Du WY, Chen ZJ, Wang J, et al. Resibufogenin protects against atherosclerosis in ApoE-/- mice through blocking NLRP3 inflammasome assembly. J Adv Res. 2025 https://doi.org/10.1016/j.jare.2025.04.029.

Xie JT, Belic N, McCullough J, Singer DH. Effects of resibufogenin on the action potential of myocardial fibers of the dog and guinea pig. Zhongguo Yao Li Xue Bao. 1985;6:169–71.

PubMed  CAS  Google Scholar 

Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472–6.

Article 

Comments (0)

No login
gif